We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
U.S. Genomics Announces New Chief Executive Officer
News

U.S. Genomics Announces New Chief Executive Officer

U.S. Genomics Announces New Chief Executive Officer
News

U.S. Genomics Announces New Chief Executive Officer

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "U.S. Genomics Announces New Chief Executive Officer"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

U.S. Genomics has announced that John J. Canepa has been promoted to President, Chief Executive Officer and member of the Board of Directors.

"John's business acumen, combined with his extensive experience in the life sciences, represents an unparalleled set of qualifications to lead this company through its commercialization efforts and the next phase of its biodefense contract," said Gus Lawlor, Managing Director at HealthCare Ventures and a U.S. Genomics board member.

"We are excited to move forward in this next phase of biodefense development and commercialization of the single molecule biology technology under John's leadership."

Canepa originally joined U.S. Genomics as Chief Financial Officer. During his tenure as CFO, Canepa saw the Company through the development and launch of the Trilogy® 2020 platform and Direct™ miRNA assays and through two phases of a multi-million-dollar biodefense contract with the U.S. Department of Homeland Security.

Prior to joining U.S. Genomics, Canepa served as Vice President, Finance & Administration, and Chief Financial Officer of Winphoria Networks, Inc., a venture capital-backed telecommunications company.

Previously he was a senior partner in the Boston office of Arthur Andersen, where he led the firm's worldwide life sciences practice.

Canepa holds a Masters in Finance from Michigan State University and a B.A. from Denison University.

"U.S. Genomics has made great strides with its biodefense work and this is an especially exciting time to be part of this company," said Canepa.

"It is a privilege to lead such a dynamic team in both the biodefense applications and the development of the Trilogy 2020 platform and assays."

Advertisement